Home
News/PR
Global Insulin Delivery Device Market

Customizations Possible - Country-wise reports, Additional company profiles, Country/Regional reports and Other Customizations. Special Discounts Available. Global Insulin Delivery Device Market Size & Trends Report Segmented by Product Type (Pens, Pumps, Needles, Syringes), Disease Type (Type 1 and 2), End-user (Hospitals, Clinics, Homecare Settings) Industry Analysis & Regional Forecast to 2030

Global Insulin Delivery Device Market Size & Trends Report Segmented by Product Type (Pens, Pumps, Needles, Syringes), Disease Type (Type 1 and 2), End-user (Hospitals, Clinics, Homecare Settings) Industry Analysis & Regional Forecast to 2030

The global insulin delivery device market is expected to grow at a CAGR of ~8% during the forecast period. The rising prevalence of diabetes globally, increasing adoption of self-administered insulin delivery devices, demand for minimally invasive insulin delivery devices, innovations in smart insulin pens and continuous subcutaneous insulin infusion (CSII) systems are some of the key driving factors fueling the market growth. However, the high cost of advanced insulin delivery devices and concerns regarding device accuracy and reliability remain major restraints impacting the growth of the insulin delivery device market. To learn more about the research report, download a sample report.

insulin-delivery-device-market

transparent

600

#12bece

‌
DESCRIPTION
TABLE OF CONTENT
METHODOLODY
SAMPLE DELIVERABLES

Overview

Insulin delivery devices refer to medical tools designed to administer insulin in a precise, safe, and convenient manner. Insulin delivery is essential for individuals with type 1 and type 2 diabetes who require insulin therapy as part of their daily disease management. These devices play a crucial role in improving patient adherence, glycemic control, and overall quality of life. Some common types of insulin delivery devices include insulin pens, pumps, injections, and smart automated delivery systems, which provide precise and convenient insulin administration, essential for maintaining glycemic control.

Insulin Delivery Device Market

To learn more about this report, download the PDF brochure

Rising prevalence of diabetes fuels demand for self-administered insulin devices

The rising global prevalence of diabetes is a major driver of growth in the insulin delivery device market. According to the International Diabetes Federation (IDF), over 589 million adults were living with diabetes in 2024, and this number is projected to reach 853 million by 2050. This surge is primarily linked to sedentary lifestyles, aging and unhealthy diet patterns, which are more pronounced in low- and middle-income regions, where access to timely diagnosis and treatment remains a challenge.

The rise in the number of diabetes cases necessitates effective management strategies, thereby driving the demand for insulin delivery devices. In particular, the growing adoption of self-administered insulin delivery devices has further contributed to this trend, offering patients greater independence and flexibility in managing their condition. Furthermore, the economic burden of diabetes is substantial, with global health expenditures related to the disease was USD 1 trillion in 2024, as reported by IDF, underscoring the need for efficient and scalable insulin delivery technologies to manage the condition.

Closed-loop integration of insulin delivery with CGM enhances diabetes management

The integration of insulin delivery devices with continuous glucose monitoring (CGM) systems represents a significant advancement in diabetes management, offering benefits for both type 1 and insulin-dependent type 2 diabetes patients. These automated systems enable real-time insulin dosing based on continuous glucose data, enhancing precision and reducing the risk of dangerous highs and lows in blood sugar levels. For individuals with type 1 diabetes who rely on constant insulin administration, this technology provides tighter glycemic control, less variability, and improved day-to-day management. For insulin-dependent type 2 diabetes patients, who may struggle with adherence or complex treatment routines, the automated delivery simplifies therapy, improves consistency, and reduces the need for manual adjustments. According to the research article published in NIH, closed-loop therapy can improve glycemic control more than conventional insulin therapy with CGM in people with type 2 diabetes. Overall, this closed-loop approach eases the daily burden of diabetes care, improves quality of life, and supports better long-term clinical outcomes.

Recent developments in the insulin delivery device market

In the past few months, leading companies have secured FDA clearance for next-generation continuous glucose monitoring and automated insulin delivery solutions, expanding treatment options for both type 1 and type 2 diabetes patients, thereby highlighting rapid innovation in diabetes care technology. These milestones mark a shift toward smarter, more user-friendly devices that improve long-term disease management, for instance:

In August 2024, Insulet Corporation announced that the FDA has cleared the Omnipod 5 automated insulin delivery system for adults aged 18 years and older with type 2 diabetes. The Omnipod 5 is the first automated insulin delivery system approved in the US for both type 1 and type 2 diabetes management
In August 2024, Abbott entered a global partnership with Medtronic to integrate its world-leading FreeStyle Libre continuous glucose monitoring (CGM) technology with Medtronic’s automated insulin delivery (AID) and smart insulin pen systems, enabling CGM-driven automatic insulin adjustments

Insulin Delivery Device Market - Segmentation

To learn more about this report, download the PDF brochure

Competitive Landscape Analysis

The global insulin delivery device market comprises several well-established and emerging players, including Medtronic plc; Insulet Corporation; Tandem Diabetes Care, Inc.; Novo Nordisk A/S; Eli Lilly and Company; Sanofi S.A.; Biocon Limited; F. Hoffmann-La Roche Ltd.; and Abbott Laboratories; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Report Metric	Details
Base Year Considered	2024
Historical Data	2023 - 2024
Forecast Period	2025 – 2030
Growth Rate	~8%
Market Drivers	Rising prevalence of diabetes globally Growing adoption of self-administered insulin delivery devices Increasing geriatric population with higher diabetes incidence Rising demand for minimally invasive and user-friendly devices Supportive government initiatives to improve diabetes care access Technological advancements in insulin delivery devices
Attractive Opportunities	Development of cost-effective smart insulin delivery solutions Integration of insulin delivery systems with continuous glucose monitoring (CGM) Expansion into emerging markets with high unmet diabetes care needs
Segment Scope	Product Type, Disease Type, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Medtronic plc; Insulet Corporation; Tandem Diabetes Care, Inc.; Novo Nordisk A/S; Eli Lilly and Company; Sanofi S.A.; Biocon Limited; F. Hoffmann-La Roche Ltd.; and Abbott Laboratories; among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Global Insulin Delivery Device Market Segmentation

This report by Medi-Tech Insights provides the size of the global insulin delivery device market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type, disease type, and end-user.

Market Size & Forecast (2023-2030), By Product Type, USD Million

- Insulin Pens
- Reusable Pens
- Disposable Pens
- Insulin Pumps
- Patch Pumps
- Tethered Pumps
- Insulin Pen Needles
- Standard Needles
- Safety Needles
- Insulin Syringes
- Others

Market Size & Forecast (2023-2030), By Disease Type, USD Million

- Type 1 Diabetes
- Type 2 Diabetes

Market Size & Forecast (2023-2030), By End-user, USD Million

- Hospital
- Clinics
- Homecare Settings
- Others

Market Size & Forecast (2023-2030), By Region, USD Million

North America
- US
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
Latin America
Middle East & Africa

Key Strategic Questions Addressed

What is the market size & forecast of the insulin delivery device market?
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the insulin delivery device market?
What are the key trends defining the market?
What are the major factors impacting the market?
What are the opportunities prevailing in the market?
Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
Who are the major players operating in the market?
What are the key strategies adopted by players?

Introduction
- Introduction
- Market Scope
  - Market Definition
  - Segments Covered
  - Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
  - Bottom-Up Approach
  - Top-Down Approach
- Market Forecasting
Executive Summary
- Insulin Delivery Device Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights

Market Overview
- Market Dynamics
  - Drivers
    - Rising prevalence of diabetes globally
    - Growing adoption of self-administered insulin delivery devices
    - Increasing geriatric population with higher diabetes incidence
    - Rising demand for minimally invasive and user-friendly devices
    - Supportive government initiatives to improve diabetes care access
    - Technological advancements in insulin delivery devices
  - Restraints
    - High cost of advanced insulin delivery devices
    - Device reliability, calibration, and accuracy concerns
    - Stringent regulatory approval processes and compliance requirements
  - Opportunities
    - Development of cost-effective smart insulin delivery solutions
    - Integration of insulin delivery systems with continuous glucose monitoring (CGM)
    - Expansion into emerging markets with high unmet diabetes care needs
  - Key Market Trends
    - Growth of closed-loop and hybrid automated insulin delivery systems
    - Increasing adoption of smart insulin pens with app-based connectivity
  - Unmet Market Needs
  - Industry Speaks

Global Insulin Delivery Device Market Size & Forecast (2023-2030), By Product Type, USD Million
- Introduction
- Insulin Pens
  - Reusable Pens
  - Disposable Pens
- Insulin Pumps
  - Patch Pumps
  - Tethered Pumps
- Insulin Pen Needles
  - Standard Needles
  - Safety Needles
- Insulin Syringes
- Others
Global Insulin Delivery Device Market Size & Forecast (2023-2030), By Disease Type, USD Million
- Introduction
- Type 1 Diabetes
- Type 2 Diabetes
Global Insulin Delivery Device Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospital
- Clinics
- Homecare Settings
- Others
Global Insulin Delivery Device Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Insulin Delivery Device Market Size & Forecast (2023-2030), By Country, USD Million
  - US
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Canada
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
- Europe Insulin Delivery Device Market Size & Forecast (2023-2030), By Country, USD Million
  - UK
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Germany
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - France
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Italy
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Spain
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Rest of Europe
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
- Asia Pacific (APAC) Insulin Delivery Device Market Size & Forecast (2023-2030), By Country, USD Million
  - China
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Japan
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - India
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Rest of Asia Pacific
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Disease Type (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
- Latin America (LATAM) Insulin Delivery Device Market Size & Forecast (2023-2030), USD Million
  - Market Size & Forecast, By Product Type (USD Million)
  - Market Size & Forecast, By Disease Type (USD Million)
  - Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Insulin Delivery Device Market Size & Forecast (2023-2030), USD Million
  - Market Size & Forecast, By Product Type (USD Million)
  - Market Size & Forecast, By Disease Type (USD Million)
  - Market Size & Forecast, By End-user (USD Million)

Competitive Landscape
- Key Players and their Competitive Positioning
  - Key Player Comparison
  - Segment-wise Player Mapping
  - Market Share Analysis (2024)
  - Company Categorization Matrix
    - Dominants/Leaders
    - New Entrants
    - Emerging Players
    - Innovative Players
  - Key Strategies Assessment, By Player (2022-2025)
    - New Product Launches
    - Partnerships, Agreements, & Collaborations
    - Mergers & Acquisitions
    - Geographic Expansion

Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

Medtronic plc
Insulet Corporation
Tandem Diabetes Care, Inc.
Novo Nordisk A/S
Eli Lilly and Company
Sanofi S.A.
Biocon Limited
Hoffmann-La Roche Ltd.
Abbott Laboratories
Other Prominent Players

Note: *Indicative list

**For listed companies

The study has been compiled based on extensive primary and secondary research.

Secondary Research (Indicative List)

Insulin Delivery Device Market - Secondary Research

Primary Research

To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.

Supply Side Stakeholders:

Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants

Demand Side Stakeholders:

Stakeholders from Hospitals, Clinics, Home Healthcare Providers, and Others

Breakdown of Primary Interviews

Insulin Delivery Device Market - Primary Interviews

Market Size Estimation

Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts

Data Triangulation

Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data

Insulin Delivery Device Market - Sample Deliverables

Insulin Delivery Device Market - Key Players

Get a sample report for competitive landscape analysis

Features of the Report

Comprehensive Market Coverage
Market Size and Forecast
Geographic & Segment Deep Dives
Strategic Insights & Competitive Landscape
Timely & Updated Data
Growth Indicators & Future Outlook
Quick Turnaround on Queries
Analyst Support
Report Customization Available
Reports in PDF & Excel

Order Report